UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

 

FORM 12b-25

 

NOTIFICATION OF LATE FILING

 
 
 
 
 
 
 
 
 
 

(Check one):   Form 10-K   ☐ Form 20-F   ☐ Form 11-K    ☒ Form 10-Q    ☐ Form 10-D   ☐ Form N-SAR    ☐ Form N-CSR
     
    For Period Ended: September 30, 2020
     
       Transition Report on Form 10-K
     
    ☐   Transition Report on Form 20-F
     
    ☐   Transition Report on Form 11-K
     
       Transition Report on Form 10-Q
     
    ☐   Transition Report on Form N-SAR
     
    For the Transition Period Ended:

 

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

PART I — REGISTRANT INFORMATION

 

BRAIN SCIENTIFIC INC.

 

Full Name of Registrant

 

 

Former Name if Applicable

 

125 Wilbur Place, Suite 170

 

Address of Principal Executive Office (Street and Number)

 

Bohemia, NY 11716

 

City, State and Zip Code

 

 

 

 

PART II — RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

 

 

 

 

  (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     
  (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
     
  (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III — NARRATIVE

 

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report portion thereof, could not be filed within the prescribed time period.

 

The Registrant has been unable, without unreasonable effort or expense, to timely compile all information for the disclosures required to be included in its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020.  The Registrant expects to file the Quarterly Report no later than the fifth calendar day following the prescribed filing date.

 

SEC 1344 (04-09)   Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

(Attach extra Sheets if Needed)

 

PART IV — OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification

 

Boris Goldstein   (917)   388-1578
(Name)   (Area Code)   (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).  
  Yes ☒     No ☐
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?  
  Yes ☒      No ☐
   
 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

The Registrant anticipates that there will be significant changes in the results of operations from the corresponding period for the last fiscal year. Research and development, professional fees, sales and marketing expenses, and general and administrative expenses have all increased substantially during the three and nine month periods ended September 30, 2020 compared to the corresponding periods in 2019, primarily relating to the Company’s increased activities to bring its products to market and additional fund-raising expenses. Such amounts are still being determined. Additionally, interest expense increased to in excess of $1.3 million during the three months ended September 30, 2020 when compared to approximately $14,000 during the corresponding period in 2019. The net loss increased to approximately $4.0 million for the nine months ended September 30, 2020, compared to approximately $1.0 million for the nine months ended September 30, 2019.

 

2

 

 

BRAIN SCIENTIFIC INC.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 16, 2020 By: /s/ Boris Goldstein
   

Boris Goldstein

Chairman, Secretary and Executive VP

 

 

3